CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Correction for Airaksinen et al., Clin. Diagn. Lab. Immunol. 10 (3) 367-375.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Airaksinen, U.
Right arrow Articles by Sarvas, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Airaksinen, U.
Right arrow Articles by Sarvas, M.

 Previous Article

Clinical and Diagnostic Laboratory Immunology, March 2004, p. 436, Vol. 11, No. 2
1071-412X/04/$08.00+0     DOI: 10.1128/CDLI.11.2.436.2004

AUTHOR'S CORRECTION

Production of Chlamydia pneumoniae Proteins in Bacillus subtilis and Their Use in Characterizing Immune Responses in the Experimental Infection Model

Ulla Airaksinen,1,{dagger} Tuula Penttilä,2,3 Eva Wahlström,1, {ddagger} Lynda Jackson,1, § Jenni M. Vuola,1 Mirja Puolakkainen,2,3 and Matti Sarvas1, *

Department of Vaccines, National Public Health Institute,1 Haartman Institute, Department of Virology, University of Helsinki,2 HUCH Laboratory Diagnostics, Division of Virology Helsinki, Finland3

Volume 10, no. 3, p. 367-375, 2003. The article byline should read as given above.

Page 367: The following footnote should be added: "§Present address: Via Guiseppe Motta 34, CH 6900 Lugano, Ticino, Switzerland."

Page 374: The Acknowledgments section should appear as shown below.

 This work was supported by contracts BIO4-CT96-0152 of the Biotechnology Program, and ERBCHGC930360 of the Capital and Mobility Program (L.J.) of the Commission of the European Union.

 We acknowledge Leena Liesirova, Outi Rautio, Irene Viinikangas, Saija Kokkoniemi, and Anja Ratilainen for skillful technical assistance. We thank P. Helena Mäkelä for her valuable contribution to the writing of this paper and Juha Heikkilä, University of Lapland, Rovaniemi, Finland, for help with statistical analysis.

Clinical and Diagnostic Laboratory Immunology, March 2004, p. 436, Vol. 11, No. 2
1071-412X/04/$08.00+0     DOI: 10.1128/CDLI.11.2.436.2004





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Airaksinen, U.
Right arrow Articles by Sarvas, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Airaksinen, U.
Right arrow Articles by Sarvas, M.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS